Although experts welcomed reports that the Central TB Division will soon switch from intermittent (three times in a week) to daily treatment for drug sensitive TB as part of 'Directly Observed Treatment (DOTS)', they said that more concrete steps needed to be taken towards implementing the recommended policy changes.
"India has taken the first steps towards adopting daily FDC regimen for drug-sensitive TB treatment or DOTS. The Revised National TB Control Programme (RNTCP) recently released new policy, which recommends implementation of a daily DOTS regimen using FDCs.
It said that while currently India uses single drug formulations for each of the drugs that are part of the recommended drug sensitive TB (DS-TB) treatment regime, it was likely that the TB programme will also introduce daily fixed-dose combinations (FDCs) as an additional step to ensuring proper treatment.
The experts include officials of Asia Pacific Network, International Treatment Preparedness Coalition - South Asia, Delhi Network of Positive People, Community Network for Empowerment (Manipur), Sankalp Rehabilitation Trust and MSF Access Campaign.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
